ProKidney Corp Correlations
| PROK Stock | USD 1.67 0.12 6.70% |
The current 90-days correlation between ProKidney Corp and Relay Therapeutics is 0.38 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProKidney Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProKidney Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
ProKidney Corp Correlation With Market
Significant diversification
The correlation between ProKidney Corp and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProKidney Corp and DJI in the same portfolio, assuming nothing else is changed.
ProKidney |
Moving together with ProKidney Stock
| 0.72 | MGTX | MeiraGTx Holdings PLC Downward Rally | PairCorr |
| 0.63 | VERA | Vera Therapeutics | PairCorr |
| 0.62 | DSGN | Design Therapeutics | PairCorr |
| 0.68 | MNMD | Mind Medicine | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ProKidney Stock performing well and ProKidney Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProKidney Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RLAY | 3.69 | (0.29) | 0.00 | (0.76) | 0.00 | 7.42 | 24.83 | |||
| STOK | 2.79 | (0.23) | 0.00 | (0.73) | 0.00 | 4.70 | 27.59 | |||
| PLRX | 3.01 | (0.32) | 0.00 | (0.54) | 0.00 | 5.02 | 20.55 | |||
| BDTX | 3.60 | (0.16) | 0.00 | (0.27) | 0.00 | 5.47 | 25.91 | |||
| ARVN | 3.40 | (0.59) | 0.00 | (0.84) | 0.00 | 4.96 | 23.09 | |||
| ACLX | 2.52 | (0.41) | 0.00 | (1.03) | 0.00 | 5.73 | 16.73 | |||
| VTYX | 4.75 | 0.16 | 0.03 | 0.40 | 4.49 | 11.35 | 35.02 | |||
| IMCR | 1.87 | (0.07) | 0.00 | (0.11) | 0.00 | 3.40 | 10.73 | |||
| PCVX | 2.22 | (0.42) | 0.00 | (0.42) | 0.00 | 3.57 | 17.15 | |||
| DICE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ProKidney Corp Corporate Management
| Ulrich Ernst | EVP Technology | Profile | |
| Aparna MD | VP Development | Profile | |
| Joseph MD | VP Devel | Profile | |
| Ashley Johns | VP Operations | Profile | |
| Carla Poulson | Chief Officer | Profile | |
| James CPA | Chief Officer | Profile | |
| Richard Williams | Senior Technology | Profile |